| |
|
|
|
|
|
|
|||
|
Blood, 15 June 2008, Vol. 111, No. 12, pp. 5734-5744. Prepublished online as a Blood First Edition Paper on March 11, 2008; DOI 10.1182/blood-2008-01-136531.
Submitted January 29, 2008
Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, United States * Corresponding author; email: blaza001{at}umn.edu.
Myeloablative conditioning results in thymic epithelial cell (TEC) injury, slow T-cell reconstitution, and a high risk of opportunistic infections. Keratinocyte growth factor (KGF) stimulates TEC proliferation and, when given pre-conditioning, reduces TEC injury. Thymocytes and TEC express androgen receptors and exposure to androgen inhibits thymopoiesis. In this study, we have investigated whether TEC stimulation via pre-conditioning treatment with KGF and leuprolide acetate (LupronTM), two clinically approved agents, given only prior to conditioning would circumvent the profound TEC and associated T-cell deficiency seen in allogeneic bone marrow transplant (BMT) recipients. Only combined treatment with KGF plus Lupron normalized TEC subset numbers and thymic architecture. Thymopoiesis and thymic output were supranormal, leading to the accelerated peripheral reconstitution of naive CD4 and CD8 T-cells with a broad V
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||